Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times

• Main Authors: Zhao, Y.J., Wee, H.L., Au, W.L., Seah, S.H., Luo, N., Li, S.C., Tan, L.C.S.
• Other Authors: EPIDEMIOLOGY & PUBLIC HEALTH
• Format: Article
• Published: 2014
• Subjects: Hoehn and Yahr stage; Parkinson's disease; Progression; Selegiline
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/53157
• Institution: National University of Singapore

10.1016/j.parkreldis.2010.11.010